Pirtobrutinib
Drug timelines are a Plus or Pro feature.
44 regulatory and trial events tracked for Pirtobrutinib, covering 2024-09-19 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: Mosunetuzumab in Combination With Pirtobrutinib in Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia (MPOWER) [Phase 2]